State Street Corp Dr Reddys Laboratories LTD Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, State Street Corp holds 4,655,853 shares of RDY stock, worth $62.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,655,853

Previous 909,905 411.69%

Holding current value

$62.2 Million

Previous $72.3 Million 1.69%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$13.99 - $79.75 $52.4 Million - $299 Million	3,745,948 Added 411.69%	4,655,853 $73.5 Million
Q3 2024 Nov 14, 2024	BUY	$75.41 - $84.21 $1.25 Million - $1.4 Million	16,641 Added 1.86%	909,905 $72.3 Million
Q2 2024 Aug 14, 2024	BUY	$68.26 - $76.19 $10.2 Million - $11.4 Million	149,768 Added 20.14%	893,264 $68.1 Million
Q1 2024 May 15, 2024	BUY	$67.36 - $77.59 $38,866 - $44,769	577 Added 0.08%	743,496 $54.5 Million
Q4 2023 Feb 14, 2024	BUY	$64.27 - $69.9 $1.57 Million - $1.71 Million	24,415 Added 3.4%	742,919 $51.7 Million
Q3 2023 Nov 14, 2023	SELL	$61.9 - $72.77 $6.5 Million - $7.64 Million	-105,030 Reduced 12.75%	718,504 $48 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $1.72 Million - $2.03 Million	32,169 Added 4.07%	823,534 $52 Million
Q1 2023 May 15, 2023	BUY	$51.63 - $56.93 $1.39 Million - $1.54 Million	27,002 Added 3.53%	791,365 $45.1 Million
Q4 2022 Feb 14, 2023	BUY	$51.15 - $57.45 $1.08 Million - $1.21 Million	21,031 Added 2.83%	764,363 $39.6 Million
Q3 2022 Nov 15, 2022	SELL	$49.9 - $57.32 $1.17 Million - $1.35 Million	-23,477 Reduced 3.06%	743,332 $38.9 Million
Q2 2022 Aug 15, 2022	SELL	$49.62 - $58.13 $6.81 Million - $7.98 Million	-137,220 Reduced 15.18%	766,809 $42.5 Million
Q1 2022 May 16, 2022	BUY	$48.27 - $65.25 $1.38 Million - $1.86 Million	28,550 Added 3.26%	904,029 $50.4 Million
Q4 2021 Feb 14, 2022	SELL	$59.5 - $67.25 $79,313 - $89,644	-1,333 Reduced 0.15%	875,479 $57.3 Million
Q3 2021 Nov 15, 2021	BUY	$60.19 - $75.29 $2.17 Million - $2.71 Million	36,024 Added 4.28%	876,812 $57.1 Million
Q2 2021 Aug 16, 2021	SELL	$62.12 - $74.2 $3.8 Million - $4.54 Million	-61,212 Reduced 6.79%	840,788 $61.8 Million
Q1 2021 May 17, 2021	BUY	$57.98 - $73.08 $4.15 Million - $5.23 Million	71,588 Added 8.62%	902,000 $55.4 Million
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $16.7 Million - $19 Million	-266,442 Reduced 24.29%	830,412 $59.2 Million
Q3 2020 Nov 10, 2020	BUY	$51.39 - $72.41 $3.78 Million - $5.33 Million	73,593 Added 7.19%	1,096,854 $76.3 Million
Q2 2020 Aug 14, 2020	SELL	$39.55 - $54.65 $163,143 - $225,431	-4,125 Reduced 0.4%	1,023,261 $54.2 Million
Q1 2020 May 11, 2020	BUY	$34.75 - $45.85 $35.7 Million - $47.1 Million	1,027,386 New	1,027,386 $41.4 Million

Others Institutions Holding RDY

# of Institutions

264

Shares Held

107M

Call Options Held

71K

Put Options Held

22.5K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.22B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Dr Reddys Laboratories LTD Transaction History